| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.48 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |